| 000 | 01562 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517221710.0 | ||
| 264 | 0 | _c20190920 | |
| 008 | 201909s 0 0 eng d | ||
| 022 | _a1932-7420 | ||
| 024 | 7 |
_a10.1016/j.cmet.2018.05.008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIepsen, Eva W | |
| 245 | 0 | 0 |
_aPatients with Obesity Caused by Melanocortin-4 Receptor Mutations Can Be Treated with a Glucagon-like Peptide-1 Receptor Agonist. _h[electronic resource] |
| 260 |
_bCell metabolism _cJul 2018 |
||
| 300 |
_a23-32.e3 p. _bdigital |
||
| 500 | _aPublication Type: Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAppetite _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlucagon-Like Peptide-1 Receptor _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacology |
| 650 | 0 | 4 |
_aLiraglutide _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aObesity _xdrug therapy |
| 650 | 0 | 4 |
_aReceptor, Melanocortin, Type 4 _xgenetics |
| 650 | 0 | 4 |
_aWeight Loss _xdrug effects |
| 700 | 1 | _aZhang, Jinyi | |
| 700 | 1 | _aThomsen, Henrik S | |
| 700 | 1 | _aHansen, Elizaveta L | |
| 700 | 1 | _aHollensted, Mette | |
| 700 | 1 | _aMadsbad, Sten | |
| 700 | 1 | _aHansen, Torben | |
| 700 | 1 | _aHolst, Jens J | |
| 700 | 1 | _aHolm, Jens-Christian | |
| 700 | 1 | _aTorekov, Signe S | |
| 773 | 0 |
_tCell metabolism _gvol. 28 _gno. 1 _gp. 23-32.e3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.cmet.2018.05.008 _zAvailable from publisher's website |
| 999 |
_c28489980 _d28489980 |
||